ABSTRACT To determine the prognosis of variant angina and the factors influencing it, 169 consecutive patients hospitalized in our coronary unit were followed for a mean of 15.3 months (range 1 to 68). Survival at 1, 2, and 3 years was 95%, 90%, and 87%, respectively; survival without myocardial infarction was 80%, 78%, and 75%. Twenty of the 22 myocardial infarctions and eight of the 14 deaths occurred within the first 3 months. Mantel-Haenszel log-rank analysis demonstrated that coronary disease, ventricular function, and the degree of disease activity were significant interdependent variables that influenced both survival and survival without infarction. At 1, 2, and 3 years, survival for patients with multivessel disease was 81%, 76%, and 66%; for patients with one-vessel disease, 97%, 92%, and 92%; and for patients without stenoses ¢ 70%, 98% at each year (p = .0003). Survival without infarction at 1 year was 88% in patients with no stenoses > 70% and 82% in patients with single-vessel disease; it did not change thereafter in either group, but was 62%, 58%, and 50% at 1, 2, and 3 years in patients with multivessel disease (p = .001). Treatment did not influence survival in any subgroup (only 14 patients died overall) or survival without infarction in patients with multivessel disease. However, in patients without multivessel disease, treatment with nifedipine, diltiazem, and verapamil improved survival without infarction compared to treatment with perhexiline maleate or long-acting nitrates alone (92% vs 67% at 1, 2, and 3 years; p < .005). Thus in addition to preventing angina, nifedipine, diltiazem, and verapamil appear to reduce complications in patients with variant angina without multivessel disease. Circulation 68, No. 2, 258-265, 1983. PROGNOSIS has been well defined in most subgroups of patients with coronary artery disease. However, the natural history of variant angina is unclear because the syndrome is characterized by frequent spontaneous exacerbations and remissions and because, except for the series described by Maseri et al. ' and Severi et al.,2 most reports involve small numbers of patients, heterogenous treatment, or different selection criteria.3 [1] [2] [3] [4] During a recent 5 year period, 169 patients with variant angina were hospitalized at our institution. All but seven underwent coronary arteriography and all survivors were seen at regular intervals after discharge at our variant angina clinic. The purpose of this article
PROGNOSIS has been well defined in most subgroups of patients with coronary artery disease. However, the natural history of variant angina is unclear because the syndrome is characterized by frequent spontaneous exacerbations and remissions and because, except for the series described by Maseri et al. ' and Severi et al.,2 most reports involve small numbers of patients, heterogenous treatment, or different selection criteria.3 [1] [2] [3] [4] During a recent 5 year period, 169 patients with variant angina were hospitalized at our institution. All but seven underwent coronary arteriography and all survivors were seen at regular intervals after discharge at our variant angina clinic. The purpose of this article is to describe the prognosis of these patients and to define the factors that influence prognosis.
Methods
Patients. The diagnosis of variant angina was made in patients meeting all of the following criteria: (1) burning or squeezing retrosternal chest pain at rest, (2) relief of the pain by nitroglycerin in less than 5 min, (3) ST segment elevation of at least 2 mm not present on the baseline electrocardiogram (ECG) but documented during pain and disappearing with relief of pain, and (4) no subsequent evidence of myocardial necrosis. Between March 1976 and August 1981, 169 patients meeting these criteria were hospitalized at the Montreal Heart Institute.
The mean age of the patients was 51 years (range 24 to 71); 117 were men and 52 were women. Thirty patients had previously had a myocardial infarction, 11 Table 1 lists the variables that were studied and their subsets. As an index of disease activity, we classified patients into three groups: those in whom attacks were rare and could only be documented by ergonovine provocation, and those with and without serious arrhythmias during attacks, since such arrhythmias may be an indicator of more severe ischemia and a worse prognosis.30 Serious arrhythmias were defined as ventricular fibrillation, ventricular tachycardia, ventricular couplets or bigeminy, second or third degree atrioventricular block, and asystole.t0
Results
During a mean follow-up period of 15.3 months (range 1 to 68), 14 of the 169 patients died and 22 others developed myocardial infarction. Twenty of the 22 myocardial infarctions and eight of the 14 deaths occurred during the first 3 months, including seven deaths and 12 infarctions within I month. Six of the 14 deaths were sudden and eight were in-hospital complications of myocardial infarction. Figure 1 illustrates the curves for survival and survival without myocardi- 
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(22.5%). Left ventricular function and the degree of disease activity also correlated with survival by univariate analysis, but a multivariate analysis indicated that these two variables correlated significantly with coronary artery disease and were thus not independent predictors of survival.
Survival curves are illustrated for each of these three variables in figure 2. At 1, 2, and 3 years, survival for patients with multivessel disease was 81%, 76%, and 66%, respectively; for patients with one-vessel disease, 97%, 92%, and 92%, respectively; and for patients without stenoses > 70%, 98% at each year. The degree of disease activity correlated with survival because no deaths occurred in the subset of 47 patients in whom attacks could be documented only by provocative testing; only four of these 47 had multivessel disease, 19 had single-vessel involvement, and 24 had no stenoses ¢ 70%. Survival was similar in patients with and without arrhythmias during attacks. Patients with normal left ventricular function had survival rates of 97%, 95%, and 91% at 1, 2, and 3 years compared with 88%, 84%, and 84% in those with abnormal left ventricular function.
Survival without myocardial infarction. Coronary artery disease, the degree of disease activity, and left ventricular function also correlated with the other end point studied, survival without myocardial infarction (table 2) . Again, coronary artery disease was the strongest predictor statistically. Multivariate analysis indicated that disease activity and left ventricular function were dependent on coronary artery disease and were thus not independent predictors of survival.
Curves for survival without infarction are illustrated for each of these three variables in figure 3 . Survival without infarction at 1 year was 88% in patients with no stenoses ¢ 70% and 82% in patients with singlevessel disease; it did not change thereafter in either group, but was 62%, 58%, and 50% at 1, 2, and 3 years in patients with multivessel disease. Myocardial infarction occurred in only two of the 47 patients whose attacks could be documented only by provocative testing. Survival without infarction at 1 year was 87% with normal and 71% with abnormal ventricular function.
The risk of myocardial infarction with survival for at least 1 month thereafter was 6/63 (9.5%) for patients without stenoses > 70%, 7/59 (11.9%) for patients with one-vessel disease, and 8/40 (20%) for those with multivessel disease (one tail, p < .05). As noted previously, all but two of the myocardial infarctions occurred within the first 3 months of follow-up.
Effect of treatment. cardial infarction during the first month, but thereafter only seven cardiac deaths and four infarctions occurred during a follow-up of at least 2 years. In most subsets of patients undergoing coronary arteriography, particularly those with stable angina, the subsequent risk for infarction or death remains relatively unchanged from year to year.31'32 The huge decrease after 3 months in the risk of infarction for variant angina patients suggests that some factors active early in the disease later disappear or that the population is composed of two subgroups with markedly different outcomes, with the smaller subgroup invariably progressing to infarction.
The extent and severity of organic coronary stenoses influence survival after myocardial infarction33 and in stable31 and unstable34 angina. This variable was also the strongest predictor of survival and survival without infarction in this study. The outcome for patients with one-vessel disease was similar to that for patients with no stenoses > 70% and markedly better than that in patients with multivessel disease, both for death and myocardial infarction. These results cannot be accu-262 rately compared with those of the study of Severi et al.2 because they considered a stenosis ¢ 50% as significant, because 31 of their 138 patients did not undergo coronary arteriography, and because only nine of the 107 with arteriography had no lesions -50%. Nevertheless, their patients with multivessel disease had a higher incidence of both death and myocardial infarction than their combined group with one-vessel disease or no significant stenoses.
Left ventricular function is an independent predictor of prognosis in medically treated patients with coronary disease35; however, its influence is most marked when severe dysfunction is present,35 an uncommon finding in variant angina. In the study of Severi et al.,2 the combined incidence of death and myocardial infarction was significantly greater in the 24 patients with diffuse hypokinesis, akinesis, or aneurysm compared with the 75 with localized hypokinesis or normal left ventriculograms. In our study, left ventricular function correlated weakly with both survival and survival without infarction, but this association was not independent of coronary artery disease. attacks decrease in number or disappear entirely during treatment in most patients who develop these complications. 38 In the study of Severi et al. ,2 nearly all patients were treated with verapamil; their good long-term prognosis despite a high prevalence of organic coronary disease contrasts with the poor prognosis noted in reports5' [7] [8] [9] in which calcium antagonists were not used. One possible explanation for this difference is that calcium antagonists reduce the incidence of myocardial infarction and death.
In this study, treatment with nifedipine, diltiazem, and verapamil did not improve survival alone but significantly improved survival without infarction compared to treatment with perhexiline maleate or nitrates alone (p = .008). Multivariate analysis demonstrated that this difference did not occur in patients with multivessel disease. In patients without stenoses B 70% a greater than threefold difference was present but did not attain statistical significance (death or myocardial infarction occurred in only seven of the 63 patients without stenoses ¢ 70%). In patients with one-vessel disease the difference between the two treatment groups at 1, 2, and 3 years was 90% vs 50% (p < .005); in all patients without multivessel disease, the difference was 92% vs 67% (p < .005).
These findings should not be accepted as definitive because of limitations in our study. Patients were not randomly assigned to the treatment groups. Those who received perhexiline maleate or long-acting nitrates alone were treated during the first 2 years of the study; thereafter all medically treated patients received nifedipine, diltiazem, or verapamil. Thus the differences in prognosis between the two groups could theoretically have been caused by inapparent changes in the patient population or an overall improvement in patient management. On the other hand, larger numbers might show that treatment affects survival as well as survival without infarction; only 14 of our patients died and only six of these deaths were sudden. Effective treatment would logically be expected to prevent sudden deaths caused by arrhythmias during attacks. Conclusive proof that the newer calcium antagonists reduce complications compared with nitrates alone or no treatment would require a large randomized study.
Nevertheless, the available data suggest that all patients with newly diagnosed variant angina without multivessel disease should initially be treated with nifedipine, diltiazem, or verapamil, not only to prevent angina but also to reduce the risk of complications. The clinical efficacy of these three drugs seems approximately equal.21 37 Because complications usually occur within the first 3 months after diagnosis and because symptoms often disappear spontaneously,25 39 lifelong treatment may not be required.
Our patients with multivessel disease had the most complications and their prognosis was not improved by the newer calcium antagonist drugs. In our opinion, coronary bypass surgery should be considered for this group. The number of patients in this study who underwent bypass surgery is too small to assess. The results of bypass surgery in variant angina are generally much worse than in stable or unstable angina,40 but some centers report excellent results when severe organic stenoses are present.41 Calcium antagonists should probably be administered postoperatively.42
